Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Elsa Mauricio Reus


Clinical Researcher

I am a pharmacist by training, with a MSc in Research and a PhD in Human Movement. On February 2019, I joined the Oxford Translational Cardiovascular Research group of Professor Charalambos Antoniades (Division of Cardiovascular Medicine, Radcliffe Department of Medicine).

As a Clinical Researcher, my main role is to run the VIP study, which aims to validate perivascular Fat Attenuation Index (FAI) in multiple computed tomography platforms. FAI is a new biomarker that detects vascular inflammation in the human coronary arteries using routine coronary computed tomography angiography (CCTA). In the CRISP-CT study, recently published in the Lancet, the group demonstrated that FAI predicts all-cause and cardiac mortality over and above clinical risk factors and the current state-of-the-art interpretation of CCTA.